|
Biotechnology Services
|
US$
300 |
|
Nov-2025 |
Doc #43198 |
|
| Printed Page Length :
22
pages |
| Number of Tables :
2 |
| Number of Figures:
1 |
|
Market Overview
|
|
While the global adoption of the 3R principle for animal testing may exert downward pressure on sales of laboratory animals and related service providers in Taiwan, the U.S. Federal Reserve’s interest rate cut cycle is expected to stimulate more active investment in the international biotechnology and pharmaceutical sector. This is likely to benefit domestic CRO and CDMO companies by facilitating the acquisition of new projects.
|
|
|
|